Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert


Search Title by author or title

Clinical outcomes after implantation of a shape-changing corneal inlay with mitomycin C

Poster Details

First Author: E.Barragan MEXICO

Co Author(s):    A. Chayet                    

Abstract Details


: To assess the safety and efficacy of the Raindrop�Â�® Near Vision Inlay (ReVision Optics, Inc., Lake Forest, CA, USA) implanted in presbyopes with treatment of 0.02% Mitomycin C (MMC).


Laser Ocular Hidalgo, Monterrey, Mexico; Codet Vision, Tijuana, Mexico. (25/50)


: 68 presbyopes were implanted with the Raindrop Inlay in the non-dominant eye under a femtosecond laser flap. 39 of these patients were implanted with the application of 0.02% MMC to the stoma, whereas 29 did not have MMC applied. Patients assessment at 6 months postop (N=17 with MMC, N=25 without MMC) included visual acuities, haze, and satisfaction.


The mean monocular uncorrected near visual acuity improved 5.7 �Â�± 1.8 lines in the inlay eye with MMC and 5.42 �Â�± 2 without MMC. 96% and 94% of patients could see 20/32 or better with and without MMC, respectively. The average distance visual acuity was 20/25 with MMC and 20/32 without MMC. With MMC, none of the patients had reported central haze at 6 months and 94.1% of patients were satisfied, whereas without MMC 9% of patients had haze and 92% of patients were satisfied.


Raindrop Inlay visual outcomes were similar with and without MMC, however, corneal haze was reduced with the addition of MMC and this resulted in higher patient satisfaction.

Financial Disclosure:

travel has been funded, fully or partially, by a competing company

Back to Poster listing